Nu-Med Plus NUMD
OTC NUMD
$0.02 +0.00 (+0.00%)
At close: Aug 17, 2026 · 4:00 PM UTC

Nu-Med Plus (NUMD) Cash from Investing Activities Growth (1y) (2013)

Nu-Med Plus (NUMD) Cash from Investing Activities Growth (1y) (2013) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Abbott Laboratories 199.67 Bn 194.07 Bn 7.27 Bn -15.64%
2 Stryker 129.56 Bn 126.09 Bn 4.50 Bn -514.42%
3 Medtronic 119.87 Bn 110.65 Bn 6.41 Bn -87.14%
4 Boston Scientific 73.80 Bn 73.27 Bn 3.85 Bn -73.71%
5 Edwards Lifesciences 52.66 Bn 48.41 Bn 1.35 Bn -12.26%
6 Dexcom 34.56 Bn 32.61 Bn 830.00 Mn 618.55%
7 GE HealthCare Technologies 34.16 Bn 32.05 Bn 2.18 Bn 48.43%
8 Koninklijke Philips 26.44 Bn 23.12 Bn 4.55 Bn 91.33%
9 Steris 23.23 Bn 22.75 Bn 684.20 Mn 0.00%
10 Nu-Med Plus 1.82 Mn 1.82 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2013 -167,800.00%